Three experts apply policy, pharmacy operations, and member-level lenses to the same prescriptions to show why cost at the ...

Katelyn B. Meyer, PharmD, discusses how payers can prepare for emerging specialty therapies, from cell and gene therapies to ...

The influx of novel therapies is expanding treatment options for patients with cancer, but distance, infrastructure, and ...

Approximately 4.3 million Medicare beneficiaries will have their plans terminated at the end of 2026—including 3.1 million ...

Most Medicaid enrollees who lost coverage during the unwinding were removed for procedural reasons, and expansion adults will ...

An 18-expert APAC panel reached consensus on 140 of 183 statements on alopecia areata diagnosis and treatment. JAK inhibitors ...

Among patients with essential thrombocythemia, higher average ropeginterferon alfa-2b exposure was associated with greater JAK2V617F allele burden reduction at 6 or 7 months (P = .021).

In “Immunotherapy in MSI-High and dMMR mCRC,” Dr. Strickler discusses how immune checkpoint inhibition has reshaped treatment ...

Among youths who misused each drug class, those with depression were more likely to cite helping with feelings and emotions as their main reason for misusing opioid analgesics (10.2% vs 3.7%; P = .01) ...

Clinicians at CHEST 2026 say costs and outcomes are shaped well beyond the ICU, from surgical choices to discharge planning and end-of-life talks. The true cost of robotic surgery, the discharge ...

Stanford's Richard Lafayette discusses 36-week povetacicept data in IgA nephropathy, including proteinuria, hematuria, and safety findings. Povetacicept, a dual inhibitor of B-cell activating factor ...

Anti-CGRP antibody exposure near conception was linked to higher spontaneous abortion risk in migraine, while propranolol was not, a cohort study found. Exposure to anticalcitonin gene-related peptide ...